Drug–drug interaction through molecular structure similarity analysis

BACKGROUND: Drug–drug interactions (DDIs) are responsible for many serious adverse events; their detection is crucial for patient safety but is very challenging. Currently, the US Food and Drug Administration and pharmaceutical companies are showing great interest in the development of improved tool...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vilar, Santiago, Harpaz, Rave, Uriarte, Eugenio, Santana, Lourdes, Rabadan, Raul, Friedman, Carol
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Group 2012
Schlagworte:
Research and Applications
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3534468/
https://ncbi.nlm.nih.gov/pubmed/22647690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/amiajnl-2012-000935
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge